BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 27306503)

  • 21. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).
    Soomro GM; Altman D; Rajagopal S; Oakley-Browne M
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001765. PubMed ID: 18253995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis.
    Tao Y; Li H; Li L; Zhang H; Xu H; Zhang H; Zou S; Deng F; Huang L; Wang Y; Wang X; Tang X; Fu X; Yin L
    J Psychiatr Res; 2022 Apr; 148():95-102. PubMed ID: 35121274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.
    Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
    PLoS Med; 2017 Jun; 14(6):e1002337. PubMed ID: 28654682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of cognitive behaviour therapy and selective serotonin reuptake inhibitors for the treatment of hypochondriasis: Implications for trial design.
    Fineberg NA; Pellegrini L; Clarke A; Perera U; Drummond LM; Albert U; Laws KR
    Compr Psychiatry; 2022 Oct; 118():152334. PubMed ID: 36007340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis.
    Zhou X; Cipriani A; Zhang Y; Cuijpers P; Hetrick SE; Weisz JR; Pu J; Del Giovane C; Furukawa TA; Barth J; Coghill D; Leucht S; Yang L; Ravindran AV; Xie P
    BMJ Open; 2017 Aug; 7(8):e016608. PubMed ID: 28801423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
    Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
    Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials.
    Suhas S; Malo PK; Kumar V; Issac TG; Chithra NK; Bhaskarapillai B; Reddy YCJ; Rao NP
    World J Biol Psychiatry; 2023 Feb; 24(2):162-177. PubMed ID: 35615998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons.
    Skarphedinsson G; Hanssen-Bauer K; Kornør H; Heiervang ER; Landrø NI; Axelsdottir B; Biedilæ S; Ivarsson T
    Nord J Psychiatry; 2015 Feb; 69(2):81-92. PubMed ID: 25142430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D; Zhang Z; Zhang X; Li L
    Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unguided Computer-Assisted Self-Help Interventions Without Human Contact in Patients With Obsessive-Compulsive Disorder: Systematic Review and Meta-analysis.
    Imai H; Tajika A; Narita H; Yoshinaga N; Kimura K; Nakamura H; Takeshima N; Hayasaka Y; Ogawa Y; Furukawa T
    J Med Internet Res; 2022 Apr; 24(4):e35940. PubMed ID: 35451993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis.
    Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G
    J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).
    Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
    Evid Based Child Health; 2013 May; 8(3):1004-116. PubMed ID: 23877914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of unguided self-help psychological interventions for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials.
    Wang Y; Amarnath A; Miguel C; Ciharova M; Lin J; Zhao R; Struijs SY; de Wit LM; Toffolo MBJ; Cuijpers P
    Compr Psychiatry; 2024 Apr; 130():152453. PubMed ID: 38290294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.